Addressing the Challenges of Cold Agglutinin Disease: From Diagnosis to Treatment

C

Sutimlimab in Cold Agglutinin Disease: Safety From the Phase 3 Cardinal and Cadenza Studies

By Catherine Broome 5 Videos
235 views
April 15, 2024
0 Comments
Login to view comments. Click here to Login
13:52
Julia Cunningham

Diagnosis and Testing Considerations for Cold Agglutinin Disease

16:07
Shirley D'Sa

Current Management of CAD and the Role of Complement Activation

23:57
Ilene Weitz

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

13:41
Kelly Davidson

CAD: The Basics and Development

18:39
Sigbjørn Berentsen

CAD: The Importance of Treatment Continuity

20:56
Kelly Davidson

Sutimlimab in Cold Agglutinin Disease

10:29
Catherine Broome

2-Year Results From the CARDINAL Study: Sutimlimab for Complement C1…

22:22
Irina Murakhovskaya

Cold Agglutinin Disease: Pharmacologic Treatment and Clinical Monito…

07:59
Keck School of Medicine of USC

CARDINAL Trial 2-Year Follow-Up: Long-Term Sutimlimab for Patients W…

Feat. I. Weitz
34:15
Scripps Health

Advances in Hemolytic Anemias: Enzymopathies, Membrane Defects, Auto…

Feat. I. Weitz
32:32
BMFcases

Refractory Cold Agglutinin Disease Overview and Case Discussion

Feat. S. Berentsen, T. Bat
12:34
Yale Cancer Center

Yale ASH Updates on Classical Hematology: PROs of Sutimlimab Use in …

Feat. G. Goshua